When Seqirus launched its new 19,000 sq. ft fill/finish facility, they required a secondary packaging solution that met the highest industry standards while ensuring efficiency, compliance, and seamless integration. Integrated Life Science Group (ILS Group) was engaged to manage the project, covering everything from design and equipment selection to full validation and installation.

Through strategic planning and execution, ILS Group successfully delivered a comprehensive secondary packaging system that aligned with Seqirus’ operational and regulatory requirements, ensuring a smooth transition from design to distribution.

The Project

Seqirus required a secondary packaging system that would:

• Ensure efficiency in packaging processes.
• Meet strict regulatory compliance standards.
• Align seamlessly with upstream and downstream operations.
• Be fully validated for immediate operational use.

ILS Group was responsible for managing every stage of the project, ensuring that all aspects—from initial design to distribution—met Seqirus’ high standards for quality and compliance.

The Approach

ILS Group’s expertise in pharmaceutical facility projects allowed us to take a structured and proactive approach to delivering this complex project. Our scope of work covered:

• Project & Cost Management: Ensuring the project remained on schedule and within budget while maintaining strict quality controls.
• Equipment Design Overview: Reviewing and refining equipment design to optimise performance and integration within the facility.
• Equipment Selection: Identifying and sourcing the most suitable secondary packaging equipment based on efficiency, compliance, and operational needs.
• Vendor Management: Coordinating with multiple suppliers to ensure timely delivery and seamless integration of all equipment.
• Full Validation Documentation: Developing comprehensive validation protocols to ensure compliance with industry standards.
• Installation Management: Overseeing the installation process to guarantee a smooth and efficient transition from planning to operational readiness.

Challenges & Solutions

1. Complex Coordination Across Multiple Stakeholders
   With various vendors and suppliers involved, managing timelines and ensuring alignment across teams was critical. ILS Group provided strong project oversight, ensuring clear communication and coordination to prevent delays and inefficiencies.
2. Regulatory Compliance Requirements
   The pharmaceutical industry demands rigorous validation and documentation. Our team developed a structured validation process that streamlined compliance while ensuring all equipment and processes met industry regulations.
3. Integration with Existing Facility Operations
   The secondary packaging system needed to align seamlessly with the broader production and distribution processes. Through careful planning and design reviews, we ensured that the new system complemented existing workflows without disruption.

The Results

The successful execution of this project delivered key benefits for Seqirus, including:

• A Fully Integrated Secondary Packaging System – Seamless alignment with production and distribution processes.
• Regulatory Compliance Assurance – Comprehensive validation documentation ensuring industry standards were met.
• Cost-Effective & Efficient Implementation – Delivered on time and within budget, optimising operational efficiency.

Seqirus now benefits from a streamlined secondary packaging system that supports its high-volume vaccine production, positioning the facility for long-term success.

Conclusion

The GOYOS project highlights ILS Group’s ability to deliver complex, compliance-driven solutions in pharmaceutical manufacturing. Our expertise in project management, equipment selection, and validation ensured that Seqirus’ new facility was equipped with a secondary packaging system that met both operational and regulatory demands.

Through meticulous planning and execution, we provided Seqirus with a future-proof packaging solution that supports the company’s mission of delivering life-saving vaccines efficiently and reliably.